Please assess the completion status of the following clinical trial:

Trial Title: Trial Assessing Cooled Radiofrequency Denervation as a Treatment for Sacroiliac Joint Pain Using the Sinergy System

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Predominantly axial pain below L5 vertebrae~* greater than 75%pain relief from 2 seperate lateral branch blocks done on different days~* chronic axial pain lasting longer than 6 months, 3 day average VAS between 4 and 8~* age greater than 18~* failed to acheive adequate improvemnet with comprehensive non-operative treatments, includingbut not limited to: activity alteration, non0steriodal anti-iflammatory, physical and/or manual therap, and flurpscopically guided steriod injections in and around the area of pathology~* all other possible sources oflow back pain have been ruled out, including but not limited to the intervertebral discs, bone fracture.~Exclusion Criteria:~* Beck Depression greater than 20%~* irreversible psychological barriers to recovery~* spinal pathology that may impede recovery such as spins bifida occulta,~* moderate to severe foraminal or central canal stenosis~* systemic infection or localized infection at inducer site~* concomitant cervical or thoracic pain greater than 2/10 on VAS~* uncontrolled or acute disease~* chronic severe condition such as rheumatoid arthritis~* preganancy~* active radicular pain~* immunosuppression~* workers compensation~* allergy to injectants or medications used in procedure~* high narcotis use greater than 30 mg hydrocodone or equivalent~* smokers~* body mass index greater than 29.9

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Treatment with Sinergy system
- 2 (Type: PLACEBO_COMPARATOR): placebo controlled

Based on this trial design, predict the completion outcome and termination type (if applicable).